Funder: National Institutes of Health
Due Dates: May 1, 2025 (Full application) | April 1, 2025 (Letter of Intent, optional)
Funding Amounts: Up to $350,000 direct costs per year, for up to 5 years (maximum $1,750,000 direct costs total)
Summary: Supports highly innovative, pioneering research by early-stage investigators on HIV comorbidities, coinfections, and complications, distinct from their current research directions.
Key Information: Single-PI, early-stage investigator (ESI) only; project must represent a new research direction; minimum 4 person-months/year effort required.